HCWB (HCW Biologics Inc.) Forward P/E Multiple
HCW Biologics Inc. (HCWB) relies on scientific recognition in the development of immunotherapies against cancer and aging. This GURU.Markets chart illustrates the company's current forward P/E ratio, where 0.00 becomes the new value for this metric. Robotic protein analysis accelerates drug development, while steady market interest in combating inflammation confirms the reliability of the brand's scientific profile.
Analytical breakdowns for HCW Biologics Inc.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
HCWB - Net Income|Future Profit HCW Biologics Inc.|HCWB - Price to Earnings Ratio|Projected Price to Earnings HCW Biologics, Inc.|HCWB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple HCW Biologics|HCWB - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) HCW Biologics|HCWB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months hcwbiologics.com|HCWB - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year HCW Biologics Inc.
- total revenue and sales volume data:
Summary company analytics:HCW Biologics
The development of HCW Biologics Inc. (HCWB) relies on the success of clinical trials for anti-inflammatory proteins and the timeliness of licensing payments from partners. Analyzing the company's consensus P/E forecast, an investor correlates the current share price with expected earnings, where extreme curve deviations signal either an undervalued asset or critical delisting risks requiring rigorous compliance control of fundamental metrics.
Competitors of HCW Biologics Inc. (HCWB)
Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Kiniksa Corp (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols, S.A.|Projected Price to Earnings ADPT|Forward P/E Multiple celldex.com|Future Price to Earnings Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Price to Future Earnings Ratio|Forward P/E Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Projected Price to Earnings Ratio|PHVS - Future Price to Earnings|ABCL - Forward P/E Multiple|Tourmaline (TRML) - Future Price to Earnings|Precigen - Future Price to Earnings Multiple|PHAR (Pharming Group NV) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics|Future Price to Earnings Upstream Bio Inc (UPB)|Forward P/E Multiple zenasbio.com (ZBIO)|Future Price to Earnings Immunome Corp IMNM|Forward P/E Multiple Gossamer Bio Inc GOSS|KALV - Future Price to Earnings|Future Price to Earnings Multiple SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Projected Price to Earnings|Savara Inc. - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals, Inc.) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Forward P/E Multiple RAPT (rapt.com)|Market Cap to Future Earnings Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Kyverna Therapeutics Inc.|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|VTYX (ventyxbio.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Theratechnologies Inc. THTX|Projected Price to Earnings AVTX (avalotx.com)|Projected Price to Earnings Eledon Pharmaceuticals, Inc. ELDN|Future Price to Earnings Agenus, Inc AGEN|Climb Bio Inc - Future Price to Earnings|Zura Bio Limited - Forward P/E Multiple|Market Cap to Projected Earnings aTyr Pharma, Inc. ATYR|ADAG: Forward P/E Multiple|Price to Expected Earnings Ratio IMA (ImageneBio)|Projected Price to Earnings STTK|EQ: Future Price to Earnings Multiple|Future Price to Earnings Connect Pharma (CNTB)|Forward P/E Multiple Immunic Therapeutics (IMUX)|Forward P/E Multiple ATRA (Atara Biotherapeutics)|Future Price to Earnings Multiple IFRX|XFOR (X4 Pharma) - Projected Price to Earnings Ratio|Future Price to Earnings Multiple ACET (adicetbio.com)|CELU: Forward P/E Multiple|inmunebio.com (INMB) - Forward P/E Multiple|BRNS (Barinthus Biotherapeutics PLC) - Forward P/E Multiple|KZR: Future Price to Earnings Multiple|Future Price to Earnings SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Future Price to Earnings Multiple|Future Price to Earnings Enlivex Therapeutics Ltd ENLV|QTTB - Projected Price to Earnings|geovax.com - Forward P/E Multiple|Future Price to Earnings Multiple EDSA (Edesa Biotech Inc)|IBIO: Forward P/E Multiple|Carisma Tx (CARM) - Forward P/E Multiple|XTLB (XTL Biopharmaceuticals) - Forward P/E Multiple|BOLT: Future Price to Earnings Multiple|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt Inc.)|Market Cap to Projected Earnings GRI Bio, Inc. (GRI)|XRTX - Future Price to Earnings|reshapelifesciences.com (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Indaptus Therapeutics, Inc. - Future Price to Earnings Multiple|Future Price to Earnings Scinai|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple
